Corbett, Kizzmekia S.
Werner, Anne P. http://orcid.org/0000-0003-2322-6830
Connell, Sarah O’
Gagne, Matthew
Lai, Lilin
Moliva, Juan I.
Flynn, Barbara
Choi, Angela
Koch, Matthew
Foulds, Kathryn E. http://orcid.org/0000-0003-4418-6495
Andrew, Shayne F.
Flebbe, Dillon R.
Lamb, Evan
Nurmukhambetova, Saule T.
Provost, Samantha J.
Bock, Kevin W. http://orcid.org/0000-0001-9454-0937
Minai, Mahnaz
Nagata, Bianca M.
Ry, Alex Van http://orcid.org/0000-0002-1240-9044
Flinchbaugh, Zackery
Johnston, Timothy S. http://orcid.org/0000-0001-9246-6155
Mokhtari, Elham Bayat
Mudvari, Prakriti
Henry, Amy R.
Laboune, Farida
Chang, Becky
Porto, Maciel
Wear, Jaclyn
Alvarado, Gabriela S.
Boyoglu-Barnum, Seyhan
Todd, John-Paul M.
Bart, Bridget
Cook, Anthony
Dodson, Alan
Pessaint, Laurent
Steingrebe, Katelyn
Elbashir, Sayda
Sriparna, Manjari http://orcid.org/0000-0003-3272-7370
Pekosz, Andrew
Andersen, Hanne http://orcid.org/0000-0003-1103-9608
Wu, Kai
Edwards, Darin K.
Kar, Swagata
Lewis, Mark G. http://orcid.org/0000-0001-7852-0135
Boritz, Eli
Moore, Ian N.
Carfi, Andrea
Suthar, Mehul S.
McDermott, Adrian http://orcid.org/0000-0003-0616-9117
Roederer, Mario
Nason, Martha C.
Sullivan, Nancy J.
Douek, Daniel C.
Graham, Barney S. http://orcid.org/0000-0001-8112-0853
Seder, Robert A. http://orcid.org/0000-0003-3133-0849
Article History
Received: 23 June 2021
Accepted: 4 August 2021
First Online: 20 August 2021
Competing interests
: K.S.C. and B.S.G. are inventors on US Patent no. 10,960,070 B2 and International Patent Application no. WO/2018/081318 entitled ‘Prefusion coronavirus spike proteins and their use.’ K.S.C. and B.S.G. are inventors on US Patent Application no. 62/972,886 entitled ‘2019-nCoV vaccine’. A.C., M.K., S.E., K.W., D.K.E. and A.C. are employees of Moderna. A.V.R., Z.F., B.C., M.P., J.W., B.B., A.C., A.D., L.P., K.S., H.A., S.K. and M.G.L. are employees of Bioqual. M.S.S. serves on the scientific board of advisors for Moderna. The other authors declare no competing interests.
Free to read: This content has been made available to all.